Archives

Ascidian to Highlight Progress of Lead Program in Stargardt and Platform Advancements Across Therapeutic Areas at ASGCT 2026 Annual Meeting

B BOSTON, April 28, 2026 /PRNewswire/ — Ascidian Therapeutics, a biotechnology company seeking to treat human diseases by rewriting RNA, today announced it will present two… Login to continue reading Login…

Read MoreAscidian to Highlight Progress of Lead Program in Stargardt and Platform Advancements Across Therapeutic Areas at ASGCT 2026 Annual Meeting

Roeslein Renewables Supports U.S. Push by ABMI to Put American-Made Biofuels at the Center of Global Maritime Fuel Framework

B WASHINGTON, April 28, 2026 /PRNewswire/ — Roeslein Renewables announced its support for a new national push to secure a central role for American‑made biofuels… Login to continue reading Login…

Read MoreRoeslein Renewables Supports U.S. Push by ABMI to Put American-Made Biofuels at the Center of Global Maritime Fuel Framework